February 11, 2015
Sanofi has accelerated its diversification strategy in the generics market to meet the needs of as many patients worldwide as possible.
Building a stronger presence in the field of branded generic medicines is an important part of our growth strategy. We have expanded our portfolio with major acquisitions in generics, including Zentiva which has become the group's European generics platform. Focusing on the needs of patients, we adopt a regional approach in order to make more of our products more affordable and available to more patients.